AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

The Israel Land Development Company Ltd.

Board/Management Information Aug 1, 2019

6886_rns_2019-08-01_bb3269dc-bba2-4c48-ab4f-24395994e87b.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 5391H

Oil and Gas Development Company Ltd

01 August 2019

No.CS04-08/PSX                                                                                August 01, 2019

The General Manager

Karachi Stock Exchange Limited

Stock Exchange Building

Stock Exchange Road

Karachi

Fax No: 021-32437567
London Stock Exchange Plc.               10 Paternoster Square

London EC4M 7LS

Tel: (44) 020 7334 8907

Subject: CHANGE / APPOINTMENT OF MD/CEO OGDCL

Dear Sir,

In continuation of our letter No. CS04-08/PSX dated July 01, 2019 (enclosed), it is informed that Mr. Zahid Mir has relinquished the charge of MD/CEO of the company on July 31, 2019 and Dr. Naseem Ahmed has assumed the charge of MD/CEO on acting charge basis with immediate effect.

The above information is submitted in compliance with PSX Regulations / Code of Corporate Governance for dissemination amongst your members please.

Yours truly,

(Ahmed Hayat Lak)

Company Secretary

Copy to:

The Commissioner (Enforcement),

Securities & Exchange Commission of Pakistan,

NIC Building,

Islamabad.

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/5391H_1-2019-8-1.pdf

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOAPBMPTMBBMMIL

Talk to a Data Expert

Have a question? We'll get back to you promptly.